Öffentliche Research-Berichte

Mega Fortune Company Limited

MGRTNASDAQ

Verkaufen

Exit all existing MGRT positions immediately; do not initiate new long exposure under any circumstance.

AXT, Inc.

AXTINASDAQ

Halten

Hold current position with strict $85.00 stop-loss and await October 29 earnings for definitive thesis confirmation.

BUUU Group Limited Class A

BUUUNASDAQ

Verkaufen

Sell all BUUU exposure immediately; do not initiate new long positions.

Shattuck Labs, Inc.

STTKNASDAQ

Halten

Hold current exposure to STTK, awaiting Q3 2026 Phase 2b trial initiation as the decisive inflection point.

Relmada Therapeutics Inc

RLMDNASDAQ

Halten

Hold existing RLMD position; await confirmed breakout above $5.09 or new insider purchases above $4.50 before adjusting exposure.

Q32 Bio Inc

QTTBNASDAQ

Halten

Portfolio Manager’s Final Trading Decision

Erasca, Inc.

ERASNASDAQ

Halten

Hold current position with partial profit-taking near $19.56 and a dynamic trailing stop starting at $17.49.

D

Damora Therapeutics, Inc.

DMRANASDAQ

Halten

Hold current position; await Phase 1/2 data readouts in late 2026–early 2027 before reassessing.

XMAX, Inc.

XMAXNASDAQ

Halten

Hold current position; await Q3 earnings or Aerora integration update before adjusting exposure.

Relay Therapeutics, Inc.

RLAYNASDAQ

Halten

Hold current position pending resolution of Zovega Phase 3 data, NCCN inclusion, or ReDiscover-2 updates.

Seagate Technology Holdings PLC

STXNASDAQ

Halten

Hold current position; await Q1 2027 earnings for resolution of symmetric bull/bear evidence.

Palantir Technologies Inc. Class A

PLTRNASDAQ

Untergewichten

Underweight PLTR: trim into the post-earnings strength, retain a measured core, and do not add at the current extended valuation.

Broadcom Inc.

AVGONASDAQ

Untergewichten

Underweight AVGO: trim approximately 25% of a full benchmark position at current levels, retain a 75% core, and wait for either a controlled reset or stronger post-earnings confirmation before adding.

Space Exploration Technologies Corp

SPCXNASDAQ

Untergewichten

Trim SPCX to an underweight position: methodically reduce exposure on strength toward $142 with a hard stop at $107.50; preserve a reduced core position for long-term upside catalysts but acknowledge material risks in cash-flow quality, dilution, and revenue sustainability.

Hertz Global Holdings Inc

HTZNASDAQ

Untergewichten

Reduce HTZ exposure by 40% at $2.12; hold remainder contingent on sustained FCF inflection and technical breakout above $2.50.

Zenta Group Company Limited Class A

ZTGNASDAQ

Untergewichten

Portfolio Manager Final Decision: ZTG

ClearOne, Inc.

CLRONASDAQ

Verkaufen

Sell immediately: CLRO is fundamentally insolvent and technically exhausted, with no verified path to profitability or merger completion.

TEN Holdings, Inc.

XHLDNASDAQ

Untergewichten

Reduce exposure by 50% at $2.81 and hold remainder with a $2.00 stop-loss, awaiting Q2 earnings for evidence of operational inflection.